LEXX
Lexaria Bioscience Corp.
NASDAQ · Healthcare · Biotechnology · CA
$14.15
+14.85%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.72x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 0.44x
Liquidity & coverage
- Current ratio
- 10.60x
- Quick ratio
- 10.60x
- Cash ratio
- 9.43x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $3.7M
Cash & dividend
- FCF / debt
- -86.81x
- Cash flow / debt
- -85.63x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of May 1, 2026